Total Payments
$4,956
2024 Payments
$540.21
Companies
30
Transactions
78
Medicare Patients
4,142
Medicare Billing
$346,482
Payment Breakdown by Category
Gifts$2,764 (55.8%)
Food & Beverage$2,192 (44.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $2,764 | 2 | 55.8% |
| Food and Beverage | $2,192 | 76 | 44.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NxThera, Inc. | $2,839 | 7 | $0 (2018) |
| NeoTract Inc. | $302.70 | 3 | $0 (2018) |
| Medtronic USA, Inc. | $246.79 | 4 | $0 (2017) |
| PROCEPT BioRobotics Corporation | $167.42 | 1 | $0 (2021) |
| Boston Scientific Corporation | $143.36 | 1 | $0 (2019) |
| Palette Life Sciences, Inc. | $128.10 | 2 | $0 (2022) |
| Daiichi Sankyo Inc. | $125.03 | 6 | $0 (2024) |
| PFIZER INC. | $107.04 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $95.14 | 5 | $0 (2024) |
| Tempus AI, Inc | $79.92 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $540.21 | 28 | Daiichi Sankyo Inc. ($85.40) |
| 2023 | $333.72 | 20 | Seagen Inc. ($74.92) |
| 2022 | $171.92 | 5 | Palette Life Sciences, Inc. ($128.10) |
| 2021 | $167.42 | 1 | PROCEPT BioRobotics Corporation ($167.42) |
| 2020 | $13.80 | 1 | Paratek Pharmaceuticals, Inc. ($13.80) |
| 2019 | $248.92 | 3 | Boston Scientific Corporation ($143.36) |
| 2018 | $151.27 | 3 | NeoTract Inc. ($111.70) |
| 2017 | $3,329 | 17 | NxThera, Inc. ($2,812) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.23 | General |
| Category: Hematology/Oncology | ||||||
| 10/24/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Oncology | ||||||
| 10/23/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NONE | ||||||
| 09/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $22.91 | General |
| 08/06/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NONE | ||||||
| 08/05/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Oncology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: NONE | ||||||
| 05/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NONE | ||||||
| 04/12/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 03/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $32.06 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2024 | PFIZER INC. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,087 | 1,145 | $267,917 | $90,067 |
| 2022 | 20 | 1,052 | 1,121 | $230,690 | $83,867 |
| 2021 | 19 | 1,043 | 1,861 | $243,830 | $98,183 |
| 2020 | 18 | 960 | 1,077 | $185,039 | $74,365 |
Total Patients
4,142
Total Services
5,204
Medicare Billing
$346,482
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 75 | 76 | $38,000 | $14,269 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $31,320 | $13,217 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 116 | $24,438 | $12,152 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 104 | $17,062 | $7,513 | 44.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 52 | $12,952 | $5,549 | 42.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 60 | 61 | $12,200 | $5,358 | 43.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 91 | 118 | $8,677 | $4,869 | 56.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 49 | 51 | $10,200 | $4,046 | 39.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 55 | 57 | $10,538 | $3,897 | 37.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 57 | $7,876 | $3,711 | 47.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 53 | 54 | $16,375 | $3,027 | 18.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 23 | 24 | $19,147 | $2,722 | 14.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $5,922 | $2,315 | 39.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2023 | 19 | 19 | $7,916 | $1,618 | 20.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 11 | 11 | $3,366 | $1,278 | 38.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 28 | 28 | $11,200 | $1,075 | 9.6% |
| 55899 | Other procedure on male genital system | Office | 2023 | 16 | 16 | $8,000 | $1,060 | 13.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 19 | 19 | $3,843 | $639.73 | 16.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 60 | 60 | $12,000 | $507.08 | 4.2% |
| 51700 | Simple bladder irrigation and/or instillation | Facility | 2023 | 16 | 16 | $1,861 | $409.28 | 22.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2023 | 19 | 19 | $1,843 | $298.11 | 16.2% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 12 | 12 | $1,568 | $248.88 | 15.9% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2023 | 33 | 34 | $853.08 | $143.67 | 16.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 15 | 16 | $759.97 | $143.39 | 18.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 75 | 78 | $39,000 | $16,012 | 41.1% |
About Dr. Todd Lehrfeld, MD
Dr. Todd Lehrfeld, MD is a Urology healthcare provider based in Manahawkin, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235273848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Lehrfeld, MD has received a total of $4,956 in payments from pharmaceutical and medical device companies, with $540.21 received in 2024. These payments were reported across 78 transactions from 30 companies. The most common payment nature is "Gift" ($2,764).
As a Medicare-enrolled provider, Lehrfeld has provided services to 4,142 Medicare beneficiaries, totaling 5,204 services with total Medicare billing of $346,482. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Manahawkin, NJ
- Active Since 02/16/2007
- Last Updated 09/12/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1235273848
Products in Payments
- Rezum (Device) $2,839
- INTERSTIM (Device) $246.79
- Urolift - UL400 (Device) $191.00
- AQUABEAM ROBOTIC SYSTEM (Device) $167.42
- REZUM (Device) $143.36
- UroLift (Device) $111.70
- Enhertu (Drug) $110.35
- XTANDI (Drug) $90.92
- Nubeqa (Drug) $80.67
- XT CDX (Device) $79.92
- KEYTRUDA (Biological) $67.43
- Lenvima (Drug) $55.98
- Optune (Device) $49.09
- TUKYSA (Drug) $48.16
- Epkinly (Drug) $40.55
- CALQUENCE (Drug) $34.71
- ENHERTU (Biological) $34.71
- Myrbetriq (Drug) $32.89
- MONJUVI (Drug) $30.64
- ERLEADA (Drug) $27.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.